NEUROPHET Statistics

Total Valuation

NEUROPHET has a market cap or net worth of KRW 251.51 billion. The enterprise value is 233.27 billion.

Market Cap	251.51B
Enterprise Value	233.27B

Important Dates

The next estimated earnings date is Thursday, June 18, 2026.

Earnings Date	Jun 18, 2026
Ex-Dividend Date	n/a

Share Statistics

NEUROPHET has 12.09 million shares outstanding.

Current Share Class	12.09M
Shares Outstanding	12.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.71%
Owned by Institutions (%)	10.93%
Float	6.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	96.18
PB Ratio	12.93
P/TBV Ratio	13.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.42
EV / Sales	89.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.21

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.28.

Current Ratio	3.61
Quick Ratio	3.49
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-0.36
Interest Coverage	-17.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-56.30%
Return on Invested Capital (ROIC)	-713.52%
Return on Capital Employed (ROCE)	-82.96%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	0.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	24,560.60
200-Day Moving Average	n/a
Relative Strength Index (RSI)	44.49
Average Volume (20 Days)	432,514

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NEUROPHET had revenue of KRW 2.62 billion and -22.39 billion in losses. Loss per share was -2,302.00.

Revenue	2.62B
Gross Profit	2.61B
Operating Income	-16.55B
Pretax Income	-22.39B
Net Income	-22.39B
EBITDA	-15.44B
EBIT	-16.55B
Loss Per Share	-2,302.00

Full Income Statement

Balance Sheet

The company has 23.77 billion in cash and 5.53 billion in debt, with a net cash position of 18.24 billion or 1,508.30 per share.

Cash & Cash Equivalents	23.77B
Total Debt	5.53B
Net Cash	18.24B
Net Cash Per Share	1,508.30
Equity (Book Value)	19.45B
Book Value Per Share	2,000.04
Working Capital	18.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.07 billion and capital expenditures -265.46 million, giving a free cash flow of -15.33 billion.

Operating Cash Flow	-15.07B
Capital Expenditures	-265.46M
Depreciation & Amortization	1.11B
Net Borrowing	4.37B
Free Cash Flow	-15.33B
FCF Per Share	-1,267.99

Full Cash Flow Statement

Margins

Gross Margin	99.85%
Operating Margin	-632.84%
Pretax Margin	-856.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NEUROPHET does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.90%
FCF Yield	-6.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUROPHET has an Altman Z-Score of 13.45 and a Piotroski F-Score of 1.

Altman Z-Score	13.45
Piotroski F-Score	1